Tong Ren Tang Healthcare Reopens IPO, Targeting HK$672M Fundraising Ahead of July 2 Closing

Tong Ren Tang Healthcare Group, the traditional Chinese medicine (TCM) medical services subsidiary of Tong Ren Tang, relaunched its Hong Kong IPO subscription today through July 2, 2026. The company is offering 108 million H-shares at HK$5.48 to HK$6.21 per share, targeting up to HK$672 million in gross proceeds. A 500-share lot requires an entry fee of HK$3,136.31. The group plans to allocate 63.7% of net proceeds toward expanding its TCM medical service network, 26.3% toward repaying bank loans, and 10% for operations. Listing is expected on July 7, with China International Capital Corporation as exclusive sponsor.
Disclaimer: The information on this page may come from third-party sources and is for reference only. It does not represent the views or opinions of Gate and does not constitute any financial, investment, or legal advice. Virtual asset trading involves high risk. Please do not rely solely on the information on this page when making decisions. For details, see the Disclaimer.
Comment
0/400
No comments